Data Science Funding Announcements & Notices
Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.
Title Sort ascending | FOA | Organization | Release Date | Expire Date | Purpose |
---|---|---|---|---|---|
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) | PAR-22-106 | NCI | The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration,… More | ||
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) | PAR-22-105 | NCI | The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration,… More | ||
Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed) | PAR-24-088 | NIMH | The purpose of this Notice of Funding Opportunities (NOFOs) is to support investigators who have interest and capability to join efforts for the discovery of in vivo chemical probes for novel brain… More | ||
Discovery of Early Type 1 Diabetes Disease Processes in the Human Pancreas [HIRN Consortium on Beta Cell Death and Survival (CBDS)] (U01 Clinical Trial Not Allowed) | RFA-DK-23-007 | NIDDK | This Notice of Funding Opportunity (NOFO) requests applications to explore human pancreatic tissues and the immune compartment for the discovery of specific signaling or processing pathways that may… More | ||
Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed) | RFA-CA-23-028 | NCI | The overall goal of this UG3/UH3 Exploratory/Developmental phased initiative is to support the discovery and development of novel natural products that are safe, nontoxic, and efficacious for cancer… More | ||
Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed) | PAR-23-171 | NINDS | The purpose of this funding opportunity announcement (FOA) is to provide investigators with access to resources provided by the Data Management Coordinating Center for Diagnostic Centers of… More | ||
Diabetes Research Centers (P30 Clinical Trial Optional) | RFA-DK-25-008 | NIDDK | This Notice of Funding Opportunity (NOFO) invites applications for Diabetes Research Centers (DRCs) that are designed to support and enhance the national research effort in diabetes, its… More | ||
Device Based Treatments for Substance Use Disorders (UG3/UH3 Clinical Trial Optional) | PAR-23-253 | NIDA | The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the development of devices to treat Substance Use Disorders (SUDs). The continuing advances in technologies offer… More | ||
Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed) | PAR-23-117 | NIAID | The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for the Developmental Centers for AIDS Research (D-CFAR) program to provide administrative and shared research… More | ||
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) | PAR-24-164 | NIMH | The National Institute of Mental Health (NIMH) Division of AIDS Research (DAR) encourages applications for Center Core grants (P30) to support HIV/AIDS Research Centers (ARC). The ARC is intended to… More |